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Abstract
Recent work has shown that primary cilia are essential for Hh signaling during mammalian 
development1–9. It is also known that aberrant Hedgehog (Hh) signaling can lead to cancer10, but 
the role of primary cilia in oncogenesis is not known. Cerebellar granule neuron precursors 
(GNPs) can give rise to medulloblastomas, the most common malignant brain tumor in 
children11,12. The primary cilium and Hh signaling are required for GNPs proliferation8,13–16. 
We asked whether primary cilia in GNPs play a role in medulloblastoma growth in mice. Genetic 
ablation of primary cilia blocked medulloblastoma growth when this tumor was driven by a 
constitutively active Smoothened (Smo), an upstream activator of Hh signaling. In contrast, 
removal of cilia was required for medulloblastoma growth by a constitutively active Gli2, a 
downstream transcription factor. Thus, primary cilia are required for, or inhibit medulloblastoma 
formation, depending on the initiating oncogenic event. Remarkably, presence or absence of cilia 
were associated with specific variants of human medulloblastomas; primary cilia were found in 
medulloblastomas with activation in HH or WNT signaling, but not in most medulloblastomas in 
other distinct molecular subgroups. Primary cilia could serve as a diagnostic tool and provide new 
insights into the mechanism of tumorigenesis.
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Abnormal activation of Hh signaling, through loss of Hh receptor, Patched1 (Ptch1), or 
activation of Smo induces medulloblastomas in mice17–22. To induce medulloblastoma we 
expressed constitutively active Smo (SmoM2) in GNPs using a human Glial Fibrillary 
Acidic Protein promoter-driven Cre (hGFAP::Cre)21. By postnatal day (P) 10, 
hGFAP::Cre; SmoM2fl/+ mice developed medulloblastoma (n = 7) (Fig. 1a). In these 
tumors, SmoM2 fused with yellow fluorescent protein localized to primary cilia (Fig. 1b). 
To investigate whether SmoM2-driven medulloblastoma formation requires primary cilia, 
we removed primary cilia from GNPs expressing SmoM2, using a conditional allele of 
Kif3a that encodes a subunit of the kinesin-II motor essential for ciliogenesis23–25. The 
removal of Kif3a and the consequent loss of cilia completely blocked tumorigenesis (n = 7). 
The cerebellum of the hGFAP::Cre; SmoM2fl/+; Kif3afl/fl mice resembled that of 
hGFAP::Cre; Kif3afl/fl mice (Fig. 1a), which fail to expand GNPs8,13. Loss of Ift88, another 
gene essential for ciliogenesis26,27 in hGFAP::Cre; SmoM2fl/+; Ift88fl/fl mice also blocked 
tumorigenesis driven by SmoM2 (Supplementary Fig. 1a).
At E16, when the number of GNPs is not affected by removing cilia8, EGL was already 
expanded with many proliferating cells in hGFAP::Cre; SmoM2fl/+ mice but not in 
hGFAP::Cre; SmoM2fl/+; Kif3afl/fl mice (Fig. 1c,d), suggesting that SmoM2 requires Kif3a 
to initiate the aberrant GNP expansion and medulloblastoma. Similar requirement of cilia for 
SmoM2-driven expansion of GNPs was observed in the hippocampal dentate gyrus4.
Activated Smo converts Gli2 into a transcriptional activator and inhibits the formation of 
Gli3 repressors that form constitutively in the absence of Hh signaling28. We hypothesized 
that constitutively active Gli2 could induce medulloblastomas in the absence of primary 
cilia. To test this hypothesis we used CLEG2 mice that upon Cre-mediated recombination 
express a constitutively active Gli2 that lacks the N-terminal repressor domain 
(Gli2ΔN)29,30. Unexpectedly, none of hGFAP::Cre; CLEG2fl/+ mice (n = 14) developed 
medulloblastoma (Fig. 2) albeit two had a different type of tumors (see below). Surprisingly, 
unlike hGFAP::Cre; CLEG2fl/+ mice, removal of primary cilia in hGFAP::Cre; CLEG2fl/+; 
Kif3afl/fl mice induced medulloblastomas between P11 and P30 (n = 11) (Fig. 2). Tumors in 
hGFAP::Cre; CLEG2fl/+; Kif3afl/fl mice contained two types of cells frequently segregated 
into distinct zones: cells with darkly stained nuclei and lightly stained cytoplasm (type 1), 
and cells with large nuclei and highly eosinophilic cytoplasm (type 2) (Fig. 2b,c). Both cell 
types were actively proliferating (Fig. 2f) and expressed Gli1, suggesting active Hh 
signaling (Supplementary Fig. 2). The type 1 tumor cells were indistinguishable from those 
in SmoM2-driven medulloblastoma18,19,21 and reminiscent of classic medulloblastoma 
cells: small round cells with high nuclear-to-cytoplasmic ratio. Type 1 cells exhibited 
immunohistological characteristics of medulloblastoma similar to those in SmoM2 tumor: 
neuronal (Tuj1), glial (GFAP and Olig2), GNP (Pax6), and granule neuron (Zic1) markers 
(Supplementary Fig. 3). hGFAP::Cre; CLEG2fl/+; Kif3afl/fl and hGFAP::Cre; SmoM2fl/+ 
mice also had very similar gene expression profiles (Fig. 2h): up-regulation of Hh-
responsive genes characteristic of medulloblastoma cells (Gli1, Gli2, Ptch1, Ptch2, Mycn, 
Ccnd2, Atoh1, and Bmi1). The expression of Gli3 and Wif1 were different between the two 
tumors likely due to the presence of type 2 tumor cells in hGFAP::Cre; CLEG2fl/+; Kif3afl/fl 
mice; type 2 tumor cells down-regulated Gli3 and up-regulated Wif1 (Fig. 2h and see 
Han et al. Page 2
Nat Med. Author manuscript; available in PMC 2010 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
below). Type 2 tumors lacked immunohistological characteristics of medulloblastoma 
markers (Supplementary Fig. 3), but expressed Sox2 (data not shown), suggesting that these 
are not medulloblastomas. Type 2 tumors were also found outside of cerebellum, suggesting 
that these cells have a different origin (Supplementary Fig. 4a). Both tumor types lacked 
primary cilia (Supplementary Fig. 5). Similar to loss of Kif3a, loss of Ift88 promoted tumor 
formation containing both type 1 and 2 tumor cells in hGFAP::Cre; CLEG2fl/+; Ift88fl/fl 
mice (Supplementary Fig. 1b).
hGFAP::Cre; CLEG2fl/+ mice developed only type 2 tumors later in life that were found 
throughout central nervous system (Supplementary Fig. 4b) and lived significantly longer 
than hGFAP::Cre; CLEG2fl/+; Kif3afl/fl mice (P < 0.0001, n = 19) (Fig. 2g). These tumors 
expressed high levels of Hh-responsive genes (Gli1, Gli2, Ptch1, Ptch2, Mycn, and Ccnd2) 
and Wnt-responsive genes (Axin2 and Wif1), but not genes associated with GNPs and 
medulloblastoma (Atoh120 and Bmi131) (Fig. 2h). Type 2 tumors in hGFAP::Cre; 
CLEG2fl/+ mice had primary cilia, excluding the possibility that they may have originated 
from cells that spontaneously lost primary cilia (Supplementary Fig. 5). Thus, loss of cilia is 
required for medulloblastoma development driven by Gli2ΔN, but not for type 2 tumors; yet, 
loss of cilia accelerated the development of the type 2 tumor (Fig. 2a–c,g).
The above results suggest that loss of primary cilia is required for Gli2ΔN-driven 
medulloblastoma development, which is in striking contrast to their requirement for 
SmoM2-driven tumorigenesis. One possible explanation for these opposite roles is that 
primary cilia are required not only for Smo function but also for Gli3 repressor 
formation2,6,7,9. Consistently, Gli3 repressor was dramatically reduced in hGFAP::Cre; 
CLEG2fl/+; Kif3afl/fl mice compared with wild-type or hGFAP::Cre; CLEG2fl/+ mice (Fig. 
2d). Gli3 expression was also significantly decreased in type 2 tumors in hGFAP::Cre; 
CLEG2fl/+ mice (Fig. 2h), suggesting Gli3 could also have an inhibitory role in these 
tumors. Since Gli3 null mutants are embryonic lethal, we removed one copy of Gli3 in mice 
expressing Gli2ΔN (hGFAP::Cre; CLEG2fl/+; Gli3Xt/+) to test if Gli3 has an inhibitory 
effect on Gli2ΔN-driven tumorigenesis. hGFAP::Cre; CLEG2fl/+; Gli3Xt/+ mice developed 
type 2 tumors and died earlier in life than hGFAP::Cre; CLEG2fl/+ mice (P < 0.02, n = 18) 
(Fig. 2g and Supplementary Fig. 6). Thus, loss of one copy of Gli3 induces earlier 
development of the type 2 tumors in the presence of primary cilia, supporting our inference 
that Gli3 repressors may mediate the inhibitory function of primary cilia in tumorigenesis 
driven by Gli2ΔN. Interestingly, hGFAP::Cre; CLEG2fl/+; Gli3Xt/+ mice did not develop 
medulloblastoma, possibly due to the presence of one copy of Gli3. Additionally, loss of 
primary cilia could interfere with other signaling pathways that contribute to 
medulloblastoma development.
While SMOM2 mutations have been observed in one case of human medulloblastoma32, 
activating mutations in GLI transcription factors have not been described in 
medulloblastoma. Thus, our mouse models reveal important roles of primary cilia in 
tumorigenesis, but might not reflect on the behavior of this organelle in human cases. To 
determine if our observations in mice are relevant to human tumors, we analyzed 38 human 
medulloblastomas for the presence of cilia. Presence of primary cilia was significantly 
associated with desmoplastic medulloblastoma (P < 0.02); whereas the absence of cilia was 
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significantly associated with anaplastic medulloblastoma (P < 0.05) (Fig. 3a and Table 1). 
Twenty-four of these samples were analyzed previously for gene expression profiling33. 
Remarkably, in these 24 samples, cilia were identified almost exclusively in tumors that 
have activation in either HH or WNT signaling (P < 0.0001, Table 1). Two of the four 
tumors with active HH signaling had inactivating mutations in PTCH133, which functions 
upstream of SMO and primary cilia5.
Our results suggest that primary cilia can be permissive or inhibitory for tumor formation 
depending on the underlying oncogenic events (Fig. 3b). Interestingly, we found that subsets 
of human medulloblastomas have primary cilia, while others do not. Our mouse models 
predict both presence and absence of primary cilia in HH signaling-driven 
medulloblastomas, but all the observed medulloblastomas with high HH signaling activity 
had primary cilia. This suggests that medulloblastomas with high HH signaling in humans 
are largely due to mutations upstream of the primary cilia such as mutations in PTCH1. 
Oncogenic mutations in downstream molecules including GLI transcription factors, which 
would require loss of repressor activity mediated by the cilia, are rare11. A recent study 
identified rare amplifications of GLI1 and GLI2 genes in medulloblastomas34, but it is not 
known if these tumors are ciliated. Analyses of more medulloblastomas for both oncogenic 
mutations and presence/absence of primary cilia will be necessary to delineate the role of 
cilia in human medulloblastoma. Interestingly, all the observed human medulloblastomas 
with high WNT signaling had primary cilia. All these tumors had mutations in CTNNB1. It 
is possible that primary cilia are also involved in WNT signaling pathway35–37 or that 
oncogenic WNT activation requires concomitant signaling through primary cilia to induce 
medulloblastoma.
Our observations suggest that the presence of primary cilia be important for tumor diagnosis 
and treatment. HH signaling mutations found in medulloblastomas, loss of PTCH1 and 
SMO activation, act upstream of primary cilia2,4–9. Ciliated medulloblastomas showing HH 
signature would be susceptible to treatments that target primary cilia. The loss of cilia in 
subgroups of medulloblastomas suggests that tumor repressor functions mediated through 
primary cilia could serve as therapeutic targets to inhibit tumor growth. GLI3 is a strong 
candidate, but primary cilia could have multiple repressor activities. Understanding the role 
of primary cilia in normal and oncogenic signaling could lead to better understanding of 
tumor development and treatment not only in medulloblastomas, but also in other tumors 
(see Wong et al, this issue).
METHODS
Mice
All animal procedures were approved by the UCSF Institutional Animal Care and Use 
Committee. Genetically modified mice used in the study were described previously: 
hGFAP::Cre39, Kif3afl/fl 24, SmoM2-YFPfl/fl 19,Ift8826, CLEG229.
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Tissue preparation and staining
Mice were injected with BrdU (50 mg kg−1) and perfused one hour later with 4% 
paraformaldehyde. The brains were postfixed overnight at 4°C. For frozen sections, brains 
were cryoprotected in 30% sucrose, embedded in OCT, and cut at 10 µm. For polyethylene 
glycol (PEG) sections, brains were dehydrated in an ethanol series, embedded in a 2:1 
mixture of PEG 1000 and PEG 1500, and cut at 8 µm. For immunostaining, sections were 
incubated with primary antibodies overnight at 4°C followed by incubation with secondary 
antibodies at room temperature for two hours. Images were taken with an Olympus AX70 
microscope, Leica SP2 or SP5 confocal microscopes, and processed using Adobe 
Photoshop.
Antibodies and reagents
The following primary antibodies were used: rat anti-BrdU (1:1000 Abcam), mouse anti-
acetylated tubulin (1:1000 Sigma), anti-GFAP (1:1000 Chemicon), anti-Tuj1 (1:500 
Covance), rabbit anti-γ-tubulin (1:1000 Sigma), anti-Zic (recognizes Zic1 and other Zic 
proteins, gift from Dr. R. Segal, Boston, 1:3000), anti-Olig2 (DF308, gift from Dr. C. Stiles, 
Boston, 1:20,000) anti-pericentrin (1:1000 Abcam), Goat anti-Pax6 (1:50 Santa Cruz) and 
chicken anti-GFP (1:500 Aves Labs). SmoM2-YFP was visualized by Anti-GFP antibody. 
Alexa Fluor-conjugated secondary antibodies (1:400 Molecular Probes) were used and 
DAPI (200 ng ml−1) was used for counter staining. Standard hematoxylin and eosin staining 
was used.
Gli1 in situ hybridization
Standard in situ protocol and antisense riboprobe from Gli1 cDNA (gift from A. Ruiz i 
Altaba) were used.
Western blot
Whole cerebella of P23 mice were lysed in RIPA buffer. Pellets were removed after 
centrifugation. Lysates were resolved in 7% SDS-PAGE gel. Rabbit anti-Gli3 antibody 
(1:500 Santa Cruz biotechnology, H280) was used for immunoblotting. This Gli3 antibody 
detects specific Gli3 bands that are absent in Gli3 mutants and non-specific bands38.
qRT-PCR
Total RNA was isolated from each tumor of an individual mouse (n = 3 per group) using 
RNeasy Mini Kit (Qiagen) and was reverse transcribed by Superscript III reverse 
transcriptase (Invitrogen). Quantitative PCR was performed on an Applied Biosystems 7900 
quantitative PCR instrument using SYBR green. Transcript levels were normalized to the 
expression levels of Gapdh and measured relative to those in wild-type cerebellum. Primer 
sequences are listed in supplementary table 1.
Human medulloblastoma samples
Sections were prepared from formalin-fixed paraffin-embedded medulloblastomas archived 
in the Neurological Surgery Tissue Bank at UCSF or Neuropathology Laboratory at St. Jude 
Children’s Research Hospital. The St. Jude tumors were from a series reported previously33 
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and processed into tissue microarrays. Sections were cut at 10 µm (UCSF) or 6 µm (St. Jude) 
and were incubated in 0.01 M citrate buffer (pH 6.0) at 95°C for 30 minutes for antigen 
retrieval before immunostaining. The analysis to detect primary cilia was done blind as to 
the diagnosis or gene expression signature of the tumor. We used antibody to acetylated 
tubulin to detect primary cilia and antibody to γ-tubulin or pericentrin to detect the basal 
body.
Statistical analysis
We used Student’s t-test to compare BrdU+ cells in the embryonic EGL, Log-rank test to 
compare survival curves, Pair Wise Fixed Relocation Randomization test in Relative 
Expression Software Tool (REST©) to compare qRT-PCR results40, and Chi-square test to 
test the association of medulloblastoma subgroups and presence/absence of primary cilia.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
ACKNOWLEDGEMENTS
We thank L.S. Goldstein at University of California San Diego for providing us with Kif3afl/fl mice; D. Rowitch at 
University of California San Francisco for SmoM2fl/+ mice; B. Yoder at University of Alabama Birmingham for 
Ift88fl/fl mice; C. Cowdrey and Neurological Surgery Tissue Bank at UCSF for human medulloblastoma samples; 
R. Segal and C. Stiles at Harvard University for anti-Zic and anti-Olig2 antibodies. We thank S. Wong, J. Reiter, D. 
Cano and S. Cervantes-Roldan for sharing unpublished data. We thank S. Vandenberg for helping with assessing 
the tumor types; J. Morris, K. Blaschke and M. Sachs for helping with qRT-PCR; R. Romero for technical 
assistance; D. Rowitch, J. Reiter, S Wong, R. Ihrie, S. Nader and T. Nguyen for comments on the manuscript. Y.-G. 
H. was, in part, supported by Mark Linder/American Brain Tumor Association Fellowship. The work was 
supported by grants from US National Institute of Health (NS28478 and HD32116) and a grant from the Goldhirsh 
foundation to A. A–B. Confocal microscopy at DERC Microscopy and Imaging Core was supported by an US 
National Institute of Health grant P30 DK063720.
REFERENCES
1. Corbit KC, et al. Vertebrate Smoothened functions at the primary cilium. Nature. 2005; 437:1018–
1021. [PubMed: 16136078] 
2. Haycraft CJ, et al. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein 
polaris for processing and function. PLoS Genet. 2005; 1:e53. [PubMed: 16254602] 
3. Rohatgi R, Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. 
Science (New York, N.Y. 2007; 317:372–376.
4. Han YG, et al. Hedgehog signaling and primary cilia are required for the formation of adult neural 
stem cells. Nat Neurosci. 2008; 11:277–284. [PubMed: 18297065] 
5. Huangfu D, et al. Hedgehog signalling in the mouse requires intraflagellar transport proteins. 
Nature. 2003; 426:83–87. [PubMed: 14603322] 
6. Liu A, Wang B, Niswander LA. Mouse intraflagellar transport proteins regulate both the activator 
and repressor functions of Gli transcription factors. Development (Cambridge, England). 2005; 
132:3103–3111.
7. May SR, et al. Loss of the retrograde motor for IFT disrupts localization of Smo to cilia and 
prevents the expression of both activator and repressor functions of Gli. Developmental biology. 
2005; 287:378–389. [PubMed: 16229832] 
8. Spassky N, et al. Primary cilia are required for cerebellar development and Shh-dependent 
expansion of progenitor pool. Developmental biology. 2008; 317:246–259. [PubMed: 18353302] 
Han et al. Page 6
Nat Med. Author manuscript; available in PMC 2010 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
9. Huangfu D, Anderson KV. Cilia and Hedgehog responsiveness in the mouse. Proceedings of the 
National Academy of Sciences of the United States of America. 2005; 102:11325–11330. [PubMed: 
16061793] 
10. Varjosalo M, Taipale J. Hedgehog: functions and mechanisms. Genes & development. 2008; 
22:2454–2472. [PubMed: 18794343] 
11. Gilbertson RJ, Ellison DW. The origins of medulloblastoma subtypes. Annual review of pathology. 
2008; 3:341–365.
12. Wechsler-Reya R, Scott MP. The developmental biology of brain tumors. Annu Rev Neurosci. 
2001; 24:385–428. [PubMed: 11283316] 
13. Chizhikov VV, et al. Cilia proteins control cerebellar morphogenesis by promoting expansion of 
the granule progenitor pool. J Neurosci. 2007; 27:9780–9789. [PubMed: 17804638] 
14. Dahmane N, Ruiz i Altaba A. Sonic hedgehog regulates the growth and patterning of the 
cerebellum. Development (Cambridge, England). 1999; 126:3089–3100.
15. Wallace VA. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell 
proliferation in the developing mouse cerebellum. Curr Biol. 1999; 9:445–448. [PubMed: 
10226030] 
16. Wechsler-Reya RJ, Scott MP. Control of neuronal precursor proliferation in the cerebellum by 
Sonic Hedgehog. Neuron. 1999; 22:103–114. [PubMed: 10027293] 
17. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and 
medulloblastoma in mouse patched mutants. Science (New York, N.Y. 1997; 277:1109–1113.
18. Hallahan AR, et al. The SmoA1 mouse model reveals that notch signaling is critical for the growth 
and survival of sonic hedgehog-induced medulloblastomas. Cancer research. 2004; 64:7794–7800. 
[PubMed: 15520185] 
19. Mao J, et al. A novel somatic mouse model to survey tumorigenic potential applied to the 
Hedgehog pathway. Cancer research. 2006; 66:10171–10178. [PubMed: 17047082] 
20. Oliver TG, et al. Loss of patched and disruption of granule cell development in a pre-neoplastic 
stage of medulloblastoma. Development (Cambridge, England). 2005; 132:2425–2439.
21. Schuller U, et al. Acquisition of granule neuron precursor identity is a critical determinant of 
progenitor cell competence to form Shh-induced medulloblastoma. Cancer cell. 2008; 14:123–134. 
[PubMed: 18691547] 
22. Yang ZJ, et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted 
progenitors or stem cells. Cancer cell. 2008; 14:135–145. [PubMed: 18691548] 
23. Rosenbaum JL, Witman GB. Intraflagellar transport. Nat Rev Mol Cell Biol. 2002; 3:813–825. 
[PubMed: 12415299] 
24. Marszalek JR, et al. Genetic evidence for selective transport of opsin and arrestin by kinesin-II in 
mammalian photoreceptors. Cell. 2000; 102:175–187. [PubMed: 10943838] 
25. Marszalek JR, Ruiz-Lozano P, Roberts E, Chien KR, Goldstein LS. Situs inversus and embryonic 
ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. 
Proceedings of the National Academy of Sciences of the United States of America. 1999; 
96:5043–5048. [PubMed: 10220415] 
26. Haycraft CJ, et al. Intraflagellar transport is essential for endochondral bone formation. 
Development (Cambridge, England). 2007; 134:307–316.
27. Murcia NS, et al. The Oak Ridge Polycystic Kidney (orpk) disease gene is required for left-right 
axis determination. Development (Cambridge, England). 2000; 127:2347–2355.
28. Huangfu D, Anderson KV. Signaling from Smo to Ci/Gli: conservation and divergence of 
Hedgehog pathways from Drosophila to vertebrates. Development (Cambridge, England). 2006; 
133:3–14.
29. Pasca di Magliano M, et al. Hedgehog/Ras interactions regulate early stages of pancreatic cancer. 
Genes & development. 2006; 20:3161–3173. [PubMed: 17114586] 
30. Roessler E, et al. A previously unidentified amino-terminal domain regulates transcriptional 
activity of wild-type and disease-associated human GLI2. Hum Mol Genet. 2005; 14:2181–2188. 
[PubMed: 15994174] 
Han et al. Page 7
Nat Med. Author manuscript; available in PMC 2010 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
31. Leung C, et al. Bmi1 is essential for cerebellar development and is overexpressed in human 
medulloblastomas. Nature. 2004; 428:337–341. [PubMed: 15029199] 
32. Lam CW, et al. A frequent activated smoothened mutation in sporadic basal cell carcinomas. 
Oncogene. 1999; 18:833–836. [PubMed: 9989836] 
33. Thompson MC, et al. Genomics identifies medulloblastoma subgroups that are enriched for 
specific genetic alterations. J Clin Oncol. 2006; 24:1924–1931. [PubMed: 16567768] 
34. Northcott PA, et al. Multiple recurrent genetic events converge on control of histone lysine 
methylation in medulloblastoma. Nature genetics. 2009; 41:465–472. [PubMed: 19270706] 
35. Corbit KC, et al. Kif3a constrains beta-catenin-dependent Wnt signalling through dual ciliary and 
non-ciliary mechanisms. Nat Cell Biol. 2008; 10:70–76. [PubMed: 18084282] 
36. Gerdes JM, et al. Disruption of the basal body compromises proteasomal function and perturbs 
intracellular Wnt response. Nature genetics. 2007; 39:1350–1360. [PubMed: 17906624] 
37. Simons M, et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a 
molecular switch between Wnt signaling pathways. Nature genetics. 2005; 37:537–543. [PubMed: 
15852005] 
38. Martinelli DC, Fan CM. Gas1 extends the range of Hedgehog action by facilitating its signaling. 
Genes & development. 2007; 21:1231–1243. [PubMed: 17504940] 
39. Zhuo L, et al. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. 
Genesis. 2001; 31:85–94. [PubMed: 11668683] 
40. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise 
comparison and statistical analysis of relative expression results in real-time PCR. Nucleic acids 
research. 2002; 30:e36. [PubMed: 11972351] 
Han et al. Page 8
Nat Med. Author manuscript; available in PMC 2010 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 1. Kif3a is required for SmoM2-driven medulloblastoma formation
(a) Hematoxylin stained sagittal sections of control and mutant cerebella. Expression of 
SmoM2 in GNPs using hGFAP::Cre induces medulloblastoma by P10. Removal of Kif3a, 
an essential gene for ciliogenesis, in SmoM2 expressing cells completely blocks 
tumorigenesis resulting in atrophic cerebella similar to those of hGFAP::Cre;Kif3afl/fl mice. 
(b) SmoM2-YFP is highly enriched in primary cilia (green, arrow) associated with the basal 
body (anti-γ-tubulin staining, shown in red, arrowhead). In hGFAP::Cre; SmoM2fl/+; 
Kif3afl/fl mice only the basal body is present (arrowhead). (c, d) BrdU incorporation (1h 
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survival) at E16. GNPs proliferation in hGFAP::Cre; SmoM2fl/+; Kif3afl/fl is similar to that 
observed in hGFAP::Cre; Kif3afl/fl or wild type mice8. In contrast, already by E16, 
hGFAP::Cre; SmoM2fl/+ mice show an expanded EGL containing significantly more 
proliferating cells. *: P < 0.05. Scale bar = 0.5 mm (a), 5 µm (b) and 100 µm (c).
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Fig. 2. Kif3a suppresses Gli2ΔN-driven medulloblastoma formation
(a–c) Hematoxylin and eosin (H&E) stained sagittal sections of control and mutant cerebella 
at P23. (a) hGFAP::Cre; CLEG2fl/+ mice have ectopic clusters of cells (arrows) without 
tumor formation. (b) All hGFAP::Cre; CLEG2fl/+; Kif3afl/fl mice develop medulloblastomas 
between P11 and P30. A green dotted line in b demarcates domains of the tumors containing 
type 1 and type 2 tumor cells (see text). (c) High magnification of red box in b, showing the 
two domains with different cell types. (d) Western blot analysis of Gli3 proteins isolated 
from P23 cerebella shows the decrease of Gli3 repressor (Gli3R) in hGFAP::Cre; 
CLEG2fl/+; Kif3afl/fl mice compared with wild-type and hGFAP::Cre; CLEG2fl/+ mice. 
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Asterisk indicates a nonspecific band, which serves as a loading control. This banding 
pattern is similar to a previous report, which showed that this Gli3 antibody detects specific 
Gli3 bands that are absent in Gli3 mutants and non-specific bands38. (e,f) BrdU-labeling (1h 
survival) reveals that the ectopic clusters in hGFAP::Cre; CLEG2fl/+ mice are not 
proliferating (arrows), while tumors in hGFAP::Cre; CLEG2fl/+; Kif3afl/fl mice contained 
many proliferating cells. (g) hGFAP::Cre; CLEG2fl/+; Kif3afl/fl mice (P < 0.001) and 
hGFAP::Cre; CLEG2fl/+; Gli3Xt/+ mice (P < 0.02) die significantly earlier than 
hGFAP::Cre; CLEG2fl/+ mice. (h) Hh-responsive genes are up-regulated in both SmoM2- 
and Gli2ΔN-driven tumors (see text). *: P < 0.05. Scale bar = 0.5 mm (a,b,e,f), 10 µm (c).
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Fig. 3. Primary cilia are present in a subset of human medulloblastomas
(a) Nine of twenty-three classic and five of six desmoplastic medulloblastomas have 
primary cilia in most cells. Eight of nine anaplastic medulloblastomas have few or no 
ciliated cells (shown is an example of non-ciliated anaplastic medulloblastoma). Cilia and 
basal bodies are stained by anti-acetylated tubulin (green, arrows) and anti-γ-tubulin (red, 
arrowheads), respectively. Scale bar = 5 µm. (b) Model summarizing results of dual roles of 
primary cilia in SmoM2- and Gli2ΔN-driven tumorigenesis. SmoM2 is insensitive to 
inhibition by Ptch1 and constitutively localizes to the cilia, where it activates Gli2 and 
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inhibits Gli3 repressor (Gli3R) formation, leading to medulloblastoma (top left). Without the 
cilia, SmoM2 cannot activate downstream pathways; cerebellum remains small as in ciliary 
mutants8 and no tumors develop (bottom left). Gli2ΔN is constitutively active and 
independent of primary cilia, yet these mice do not develop medulloblastoma possibly due 
to thepresence of Gli3 repressor; however, these mice develop type 2 tumors later in life (top 
right). In the absence of cilia, Gli2ΔN induces medulloblastoma and type 2 tumors earlier in 
life. This may be due to the elimination of Gli3 repressor when cilia are removed (bottom 
right).
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Table 1
Primary cilia are present almost exclusively in medulloblastomas with either HH or WNT signaling activation.
aSamples that were hard to be determined for the presence of cilia due to suboptimal staining are labeled as equiv.
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